|
|
|
SOUTHERN AFRICA: India/South Africa cheap AIDS drugs venture announced
[This report does not necessarily reflect the views of the United Nations]
JOHANNESBURG, 7 February (PLUSNEWS) - Indian drug company Ranbaxy and South Africa's Community Investment Holdings (CIH) have agreed to jointly supply cheaper anti-AIDS drug to three Southern African countries.
Ranbaxy will hold a 70 percent stake in the joint venture while CIH, which has investments in key areas of technology, logistics and health, will hold the remaining 30 percent.
In a statement Ranbaxy said high-quality low-cost antiretrovirals (ARVs) would be distributed by governments, aid groups, AIDS management companies and retail pharmacies in South Africa, Botswana and Namibia.
The Indian drug manufacturer, which has a significant presence in South Africa, has been providing generic ARVs at affordable prices to other developing countries hard-hit by the pandemic.
[ENDS]
:: MORE NEWS BRIEFS ::
|
|
|
|
|
|
|
| Links |
· AIDS Media Center
|
· The Global Fund to fight AIDS, Tuberculosis & Malaria
|
· International Community of Women Living with HIV/AIDS
|
· AEGIS
|
· International HIV/AIDS Alliance
|
PlusNews does not take responsibility for info in links supplied.
|
|
|
|
|
[Back] [Home Page]
Click here to send any feedback, comments or questions you have about PlusNews Website or if you prefer you can send an Email to Webmaster
Copyright © IRIN 2006
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN Office for the Coordination of Humanitarian Affairs.
|
